Morris, Natalie M. https://orcid.org/0000-0001-5783-5832
Djehizian, Alexandre https://orcid.org/0000-0002-9432-9135
Mittapelly, Naresh https://orcid.org/0000-0003-0130-4519
Telaprolu, Krishna Chaitanya https://orcid.org/0000-0002-3439-7152
Holland, Bryan W. https://orcid.org/0009-0005-2658-9807
McNally, Kevin https://orcid.org/0000-0002-2089-7498
Polak, Sebastian https://orcid.org/0000-0001-8614-0642
Jamei, Masoud https://orcid.org/0000-0002-3443-0194
Alam, Khondoker https://orcid.org/0000-0001-8757-2412
Tsakalozou, Eleftheria https://orcid.org/0000-0003-1993-8528
Donnelly, Mark https://orcid.org/0000-0001-7537-9615
Feng, Kairui https://orcid.org/0009-0007-5206-1920
Bois, Frederic Y. https://orcid.org/0000-0002-4154-0391
Article History
Received: 29 October 2025
Accepted: 26 January 2026
First Online: 3 April 2026
Declarations
:
: Some of the authors are employees and potential shareholders of Certara Inc. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement, by FDA/HHS, or the U.S. Government.